As of May 27
| +0.03 / +1.26%|
The 1 analysts offering 12-month price forecasts for Genetic Technologies Ltd have a median target of 6.61, with a high estimate of 6.61 and a low estimate of 6.61. The median estimate represents a +173.15% increase from the last price of 2.42.
The current consensus among 1 polled investment analysts is to Buy stock in Genetic Technologies Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.